The business model of Joint Corp primarily focuses on providing chiropractic care services. Joint Corp operates a network of chiropractic clinics across the United States, offering convenient and affordable access to chiropractic adjustments. Their model involves providing membership plans and walk-in options for individuals seeking chiropractic treatment for common health issues, including neck and back pain. Joint Corp's unique approach aims to offer standardized care through its proprietary software system, ensuring consistent treatment techniques across their clinics. By emphasizing a membership-based model, Joint Corp aims to create long-term relationships with their customers, enhancing accessibility and affordability for chiropractic care services.

Joint Corp is primarily active in the healthcare industry.

The main competitors of Joint Corp in the market include chiropractic clinics and wellness centers that offer similar services and treatments for musculoskeletal conditions. Some notable competitors include AmeriCare Physical Therapy, The Joint Chiropractic, and The Joint...the chiropractic place. These competitors, like Joint Corp, aim to provide quality chiropractic care and wellness solutions to their customers. However, Joint Corp stands out due to its unique business model of providing affordable and convenient chiropractic services through its nationwide network of franchised clinics.

The Joint Corp, founded in 1999, is a leading chiropractic care company based in Scottsdale, Arizona. With a mission to improve the quality of life through chiropractic care, the company operates over 600 clinics across the United States. Joint Corp provides convenient, affordable, and accessible chiropractic services, focusing on subluxation correction and wellness care. Over the years, the company has developed a reputation for its patient-centered approach, fostering long-term relationships with clients. With a strong commitment to promoting the benefits of chiropractic care, Joint Corp continues to expand its presence and deliver high-quality healthcare services to individuals seeking natural pain relief and improved mobility.

Joint Corp, a leading company in the chiropractic care industry, has achieved several significant milestones in its journey. Over the years, Joint Corp has successfully expanded its network of chiropractic clinics across the United States, providing accessible and high-quality care to thousands of patients. The company also went public in 2014, increasing its financial stability and allowing for further growth and innovation. Joint Corp has been recognized for its exceptional franchise model, attracting talented chiropractors to join its team and contribute to its success. Through strategic partnerships and continuous advancements in technology, Joint Corp continues to solidify its position as a trusted and pioneering name in the chiropractic care market.

The Joint Corp is a dynamic and innovative company that focuses on revolutionizing the chiropractic care industry. With a commitment to improving the quality of life for their patients, the Joint Corp values convenience, affordability, and accessibility. Their corporate philosophy revolves around providing exceptional chiropractic services that are easily accessible to individuals from all walks of life. By offering affordable pricing and eliminating the need for insurance, the Joint Corp aims to make chiropractic care a staple in everyone's wellness routine. Their dedication to patient satisfaction, superior service, and positive outcomes sets them apart in the healthcare industry.

Analysts currently set an average price target of 10,88 USD for the Joint stock (median: 9,18 USD), implying +32,4 % versus the latest price. The consensus is based on 10 analyst ratings.

Joint Prezzi Obiettivo Analisti 2026

10 analysts currently rate the Joint stock: 6 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Joint to generate revenue of 60,29 Mio. USD and earnings per share of 0,29 USD.

Joint Prezzi Obiettivo Analisti 2026

Converted at the current exchange rate, the Joint share trades at 7,03 EUR (8,22 USD).

The Joint share (JYNT) is listed on 1 stock exchanges, including: NASDAQ (JYNT).

The company Joint Corp is a company specializing in the healthcare industry. With over 520 locations in the USA, the company is a leading provider of chiropractic services. The business model of Joint Corp is based on providing chiropractic services. The company offers a wide range of services to help people relieve their pain and discomfort. The services mainly focus on improving the mobility and function of the neck, back, shoulders, and other areas of the body. Joint Corp also offers various products to help alleviate painful symptoms. These include things like special pillows and sleep masks that help people sleep better. In addition, Joint Corp also offers dietary supplements that are intended to improve overall body health. The company also uses various marketing strategies to attract customers. These include digital marketing campaigns and marketing on social media. Joint Corp also collaborates with third-party partners and ensures that the staff in customer contact is friendly and courteous. The company seems to be successful as it is experiencing steady growth and successfully offers its services. Joint Corp has various divisions. The main business division is chiropractic services. In addition, the company is also involved in the healthcare products sector. Joint Corp also has a range of wellness and health programs. These programs are designed to help customers improve their mobility and function and promote their overall health. Joint Corp is a company dedicated to providing chiropractic services. It uses various marketing strategies to attract customers and offers a wide range of products to help people with pain and discomfort. In addition, Joint Corp offers various wellness and health programs. In summary, Joint Corp is a company dedicated to improving the health and well-being of its customers.

Il attesa fatturato di Joint ammonta a 60,29 Mio. USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.

Il attesa profitto di Joint ammonta a 4,19 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.

Il rapporto prezzo/utili (P/E) di Joint è attualmente 28,61. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Joint.

Il rapporto prezzo/fatturato (P/S) di Joint è attualmente 1,99. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Joint.

Il Quality Score AlleAktien per Joint è 1/10.

L'ISIN di Joint è US47973J1025. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.

Il WKN di Joint è A12FCC. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.

Il ticker di Joint è JYNT. Con questo simbolo di borsa vengono negoziate le azioni Joint in borsa.

Joint ha pagato dividendi ogni anno negli ultimi 0 anni.

Joint è assegnato al settore 'Sanità'.

I dividendi di Joint sono distribuiti in USD.